On December 10, 2025, Structure Therapeutics Inc. (GPCR) completed a follow-on public offering of American Depositary Shares (ADSs) and pre-funded warrants. The 8-K filing disclosed gross proceeds of $650.0 million to the company from the offering, according to the SEC document.

The offering consisted of 8,461,538 ADSs and pre-funded warrants to purchase 1,538,462 ADSs at $65.00 per ADS, according to the underwriting agreement dated December 9, 2025. The company expects the offering to close on December 11, 2025, subject to customary closing conditions. CEO Raymond Stevens signed the report on behalf of Structure Therapeutics Inc.

The securities were offered under an effective shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC). Legal opinions were provided by Travers Thorp Alberga, Zhong Lun Law Firm, and Cooley LLP regarding the legality and enforceability of the securities, as detailed in exhibits 5.1, 5.2, and 5.3 of the filing.